E. Osman Irrevocable Trust Ronald III serves as Executive at Inhibitor Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, E. Osman Irrevocable Trust Ronald III has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 1, 2024 involved receiving (via award) 50,000 shares valued at $0.
E. Osman Irrevocable Trust Ronald III currently holds 23,564,985 shares of Inhibitor Therapeutics, Inc. (INTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, E. Osman Irrevocable Trust Ronald III has been a net neutral trader of INTI stock. They have purchased $0 and sold $0 worth of shares.
E. Osman Irrevocable Trust Ronald III's most recent insider trade was on Apr 1, 2024, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |